MHRA and NHS Ethics Approval Received for ENDOCAN Phase 2 Clinical Trial for Endometriosis

Ananda Pharma is pleased to announce that NHS Health Research Authority (HRA) and MHRA approval have been received for the ENDOCAN Phase 2 clinical trial investigating the safety and efficacy